100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4,6 TrustPilot
logo-home
Examen

NRNP 6665-01 Week 11 Final Exam Solutions 2026/2027 Complete Final Exam Guide | Actual Questions & Verified Solutions | PMHNP Lifespan Psychiatry | Pass Guarantee

Puntuación
-
Vendido
-
Páginas
25
Grado
A+
Subido en
22-01-2026
Escrito en
2025/2026

NRNP 6665-01 Week 11 Final Exam Solutions 2026/2027 Complete Final Exam Guide | Actual Questions & Verified Solutions | PMHNP Lifespan Psychiatry | Pass Guarantee

Institución
NRNP 6665-01
Grado
NRNP 6665-01










Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Escuela, estudio y materia

Institución
NRNP 6665-01
Grado
NRNP 6665-01

Información del documento

Subido en
22 de enero de 2026
Número de páginas
25
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

Vista previa del contenido

NRNP 6665-01 Week 11 Final Exam Solutions 2026/2027
Complete Final Exam Guide | Actual Questions & Verified
Solutions | PMHNP Lifespan Psychiatry | Pass Guarantee



1.​ A 17-year-old presents with 4 months of insomnia, irritability, and 6 lb weight
loss. Parents report 3 weeks of pressured speech, starting 4 projects, and
staying up until 3 a.m. playing guitar. PHQ-9: 6, GAD-7: 8, MDQ: 7/13 positive.
Urine tox negative. Past meds: sertraline (no benefit). What is the most accurate
diagnosis?​
A. Major depressive disorder​
B. ADHD, combined presentation​
C. Bipolar I disorder, manic episode​
D. Cannabis-induced mood disorder​
Correct Answer: C​
Rationale: Clear manic syndrome (>3 weeks, decreased need for sleep, pressured
speech, multiple projects, functional change) plus MDQ screen positive; sertraline
non-response supports bipolar spectrum. ADHD does not explain acute sleepless
hyperactivity. Tox screen negative rules out substance-induced.
2.​ A 62-year-old woman with HTN, T2DM, and CKD (eGFR 35) has had two prior
depressive episodes; now PHQ-9: 19. Current meds: metformin, lisinopril. Which
first-line antidepressant best balances efficacy and safety?​
A. Duloxetine 30 mg daily​
B. Sertraline 50 mg daily​
C. Bupropion XL 150 mg daily​
D. Nortriptyline 25 mg nightly​
Correct Answer: B​
Rationale: Sertraline has strong evidence, minimal renal adjustment, low
drug-drug interaction. Duloxetine can raise BP and requires dose reduction in
CKD. Bupropion lowers seizure threshold and is renally cleared. Nortriptyline has
anticholinergic/cardiac risk.
3.​ A 9-year-old boy (weight 32 kg) is diagnosed with ADHD, combined type. No
cardiac symptoms. BP 98/60, HR 82, ECG normal. Which FDA-approved stimulant
and dose is most appropriate to initiate?​
A. Methylphenidate ER 18 mg qAM​

, B. Amphetamine/dextroamphetamine mixed salts 5 mg BID​
C. Atomoxetine 40 mg daily​
D. Clonidine ER 0.1 mg nightly​
Correct Answer: A​
Rationale: MPH-ER 18 mg ≈ 0.56 mg/kg—middle of guideline starting range
(0.3–1 mg/kg/day). BID amphetamine may cause afternoon rebound.
Atomoxetine is second-line, slower onset. Clonidine monotherapy is for tics or
insomnia, not first-line for core ADHD.
4.​ A 24-year-old Army veteran reports nightmares, hypervigilance, and emotional
numbing since return 18 months ago. Nightmares occur 5×/week, causing
daytime fatigue. Prazosin 1 mg qHS tried × 4 weeks without benefit. BP 118/74.
Which next step is best?​
A. Increase prazosin gradually to 6–10 mg qHS​
B. Switch to clonidine 0.1 mg BID​
C. Start risperidone 1 mg BID​
D. Begin sertraline 50 mg daily​
Correct Answer: A​
Rationale: APA PTSD guidelines: titrate prazosin for trauma nightmares to 6–10
mg (max 15 mg). Studies show dose-response. Clonidine lacks nightmare
evidence. Risperidone is not first-line for PTSD without psychosis. SSRIs help
global PTSD but specific nightmare often requires prazosin.
5.​ A 35-year-old woman with bipolar I (last manic episode 2 years ago) on lithium
900 mg qHS reports 3 weeks of sadness, fatigue, hypersomnia, and 8 lb weight
gain. Lithium level 0.9 mEq/L, TSH 4.8 µIU/mL (high-normal), creatinine 0.9.
PHQ-9: 17. Which is the best next step?​
A. Increase lithium to achieve level 1.2 mEq/L​
B. Add bupropion XL 150 mg qAM​
C. Add lamotrigine 25 mg daily, titrate upward​
D. Switch lithium to valproate​
Correct Answer: C​
Rationale: Lithium-induced hypothyroidism can present with depressive
symptoms; adding lamotrigine is evidence-based for bipolar depression without
increasing mania risk. Increasing lithium may worsen hypothyroidism. Bupropion
carries mania risk without mood stabilizer. Switching lithium loses long-term
mania prophylaxis.
6.​ A 78-year-old man with Alzheimer’s (MMSE 18) develops agitation, hitting staff
during care. Medical work-up negative. He is on donepezil 10 mg, memantine 10
mg BID. Which pharmacologic option is best?​
A. Start risperidone 0.25 mg BID​

, B. Start sertraline 50 mg daily​
C. Start lorazepam 0.5 mg PRN​
D. Increase memantine to 15 mg BID​
Correct Answer: A​
Rationale: APA/AAGP: low-dose risperidone (0.25–0.5 mg) is first-line for severe
physical aggression in dementia when non-pharmacologic failed. Black-box
warning for mortality; use lowest dose shortest time. SSRIs ineffective for
agitation. Benzodiazepine increases falls, confusion. Memantine max already 20
mg/day.
7.​ A 16-year-old female reports 6 months of restrictive eating, 15 % weight loss,
amenorrhea, and marked body-image distortion. BMI 16.5. Vital signs stable.
Which medication is contraindicated?​
A. Fluoxetine 20 mg daily​
B. Olanzapine 2.5 mg nightly​
C. Bupropion XL 150 mg daily​
D. Escitalopram 10 mg daily​
Correct Answer: C​
Rationale: Bupropion lowers seizure threshold and is contraindicated in anorexia
nervosa due to seizure risk with low weight. Fluoxetine is first-line for comorbid
depression after weight restoration. Olanzapine can aid weight gain and
obsessional thinking.
8.​ A 42-year-old man with OCD has persistent contamination fears despite CBT and
fluoxetine 80 mg × 12 weeks (Y-BOCS 26). Level is therapeutic. Which
augmentation strategy is best supported?​
A. Add risperidone 1 mg daily​
B. Add aripiprazole 5 mg daily​
C. Add clomipramine 50 mg daily​
D. Add memantine 10 mg BID​
Correct Answer: B​
Rationale: APA OCD guidelines: low-dose aripiprazole (5–10 mg) has strongest
RCT evidence for SSRI-refractory OCD. Risperidone data weaker. Clomipramine
augmentation limited by SRI overlap and cardiac risk. Memantine evidence is
preliminary.
9.​ A 29-year-old woman 28 weeks pregnant with recurrent MDD (PHQ-9 18).
Previous response to sertraline. She is medication-naive this pregnancy. Which
treatment is best?​
A. Start sertraline 50 mg daily​
B. Start paroxetine 20 mg daily​
C. Start nortriptyline 75 mg daily​

Conoce al vendedor

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
TutorRicks Chamberlain College Of Nursing
Ver perfil
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
205
Miembro desde
2 año
Número de seguidores
50
Documentos
2141
Última venta
1 día hace

3.7

27 reseñas

5
14
4
3
3
4
2
1
1
5

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes